MH
Mark Hopman sold $13K of BBNX stock
Mark Hopman, Chief Commercial Officer of Beta Bionics, Inc. (BBNX), sold 775 shares of BBNX stock worth $13K, per an SEC Form 4 filed Nov 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 16, 2026, 2 days before it was made public.
BBNX has moved -12.2% since the trade date, from $15.21 to $13.36 (Nov 20, 2026 close).
- Traded
- Nov 16, 2026
- Disclosed
- Nov 18, 2026
- Filing delay
- 2 days
- Price since
- -12.2%
- Role
- Chief Commercial Officer
- Source
- SEC Form 4